15 Mar 2019

AVLS HOSTS Virtual Reality-BASED COURSE ON SCLEROTHERAPY

The American Vein & Lymphatic Society is offering a full day course on sclerotherapy featuring its new virtual reality hands-on training. The sclerotherapy course will be offered at 8 a.m. April 6 at the Sheraton Suites Chicago O’Hare in Rosemont, Illinois.             Register at phleboloy.org.

0
14 Mar 2019

 AMERICAN VEIN & VASCULAR INSTITUTE IS CELEBRATING ITS 10-YEAR ANNIVERSARY

    American Vein & Vascular Institute is now celebrating its 10-year anniversary with special events at each of the seven clinics located throughout Colorado. Patient specials and community engagements invite patients and regional residents alike to join in on American Vein’s success and hard-earned longevity. American Vein & Vascular

0
13 Mar 2019

HOW MUCH DIFFERENCE WILL ELI LILLY’S HALF-PRICE INSULIN MAKE?

  By Bram Sable-Smith When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid another $280.51. “It eats at me to know that taxpayer money is being wasted,” said Gilmer, who has Medicare and was diagnosed with Type 1 diabetes while

0
07 Mar 2019

FDA COMMISSIONER SCOTT GOTTLIEB RESIGNS

U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, resigned March 5, but will remain in his position until April 5. Dr. Gottlieb, who has led the FDA since May 2017, did not offer a reason for his departure in his resignation letter, although he included: “We were strong

0
19 Jan 2019

ELECTRONICS INDUSTRY WANTS A SLICE OF THE HEALTHCARE REVENUE PIE

By Eric Taub If the scores of personal health care devices at the Consumer Electronics Show in January are any indication, it’s clear that the Apple Watch has kicked off a rush by high-tech companies to capitalize on people’s worries about their health. The latest version of the watch, which was

0
09 Jan 2019

ENDOLOGIX RECALLS NELLIX SYSTEM FOR PATIENT SAFETY

Endologix Inc., a developer and marketer of treatments for aortic disorders, has stopped unrestricted sales and use of the Nellix System in order to ensure optimal outcomes for patients. The existing inventory will be voluntarily recalled as described in a Field Safety Notification (FSN) issued in January. The Nellix System

0
08 Jan 2019

INTERVENTIONAL RADIOLOGY SOCIETIES CALL FOR EXPANDED STROKE TRAINING

The Society of Interventional Radiology (SIR), the Cardiovascular and Interventional Radiology Society of Europe and the Interventional Radiology Society of Australasia have formed a Joint Commission committed to providing necessary stroke training to interventional radiologists in order to alleviate the shortage of physicians trained in endovascular stroke therapies. The ability for patients

0
07 Jan 2019

MDLINX SURVEY: MAJORITY HAVE LOST FAITH IN VALUE OF THE MOC

A survey of 515 U.S. physicians by MDLinx revealed that 65 percent want to see the 10-year maintenance of certification (MOC) process ended because it adds no clinical value to the practice of medicine. The recent survey, reported in FierceHealthcare, found that almost 55 percent of respondents want to see those controversial MOC requirements

0
07 Jan 2019

MEDTRONIC GETS OK TO STUDY PATIENTS WITH BICUSPID AORTIC VALUES USING COREVALVE EVOLUT TAVR SYSTEM

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for Medtronic to initiate a single-arm study to evaluate the CoreValve Evolut TAVR system in patients with bicuspid aortic valves who are at low risk of surgical mortality. Medtronic separately received FDA approval for revised commercial

0
05 Jan 2019

IT’S A LITTLE-KNOWN SECRET THAT PATIENTS CAN GET THOUSANDS OF DOLLARS DIRECTLY FROM A DRUGMAKER

      By Sarah Jane Tribble   Kip Burgess was relieved last year when pharmaceutical giant Amgen overnighted him a $2,976 check to help pay for his go-to arthritis drug, Enbrel. The 36-year-old psychologist had run into an increasingly common problem: The copay coupon sent by Thousand Oaks, Calif.-based Amgen

0